Rapid Medical Diagnostic Devices Market - Insights
Rapid medical diagnostic devices provide test results within a minimum amount of time ranging from under a minute to up to a few minutes. Rapid medical diagnosis involves testing of the samples to identify the cause behind a disease and start the treatment. Rapid diagnosis helps in early detection of diseases, which would aid in adopting an optimal treatment plan. Diagnosis using rapid medical diagnosis devices is often a non-invasive approach, which makes frequent testing possible, and treatment can be effectively validated. Rapid diagnosis requires only a small amount of sample and the procedure is quicker. Rapid medical diagnostic devices make use of innovative technologies such as lateral flow and agglutination assays as well as biosensors. Some of the commercially available rapid medical diagnostic devices include Uni-Gold HIV, Accu-Chek Aviva meter, Alere I Influenza A & B, and ICON SC Strep A.
Rising demand for decentralized (point of care) testing
Demand for decentralized testing is rising, owing to factors such as less time consumption, independence from centralized laboratories, and cost-effectiveness. Rapid diagnostic testing aid patients by conducting testing process at the comfort of their homes, which is convenient and helps in early diagnosis and treatment. This is expected to significantly affect treatment outcomes. Manufacturers such as Alere, Inc., Roche, and Danaher Corporation are providing faster operating, easy-to-use, and reliable rapid diagnostic devices, to cater to rising demand for rapid diagnosis from patients and healthcare providers. Large population base in certain rural areas do not have adequate access to laboratory testing facilities, therefore, demand for rapid diagnostic devices from these is increasing. Rapid diagnostic devices aid in improving treatment outcomes by rapid testing and disease monitoring. Furthermore, diseases requiring constant monitoring such as diabetes, wherein, real-time physician counselling is necessary, rapid diagnostic medical devices such as glucometers have proven to be highly effective, which is further boosting growth of the market.
The global rapid medical diagnostic devices market was valued at US$ 17,078.1 million in 2016 and is expected to witness a robust CAGR of 8.2% over the forecast period (2017–2025).
Figure 1. Global Rapid Medical Diagnostic Devices Market Share, by Technology (%) 2017 and 2025
Increasing prevalence of chronic diseases is expected to boost the demand for rapid diagnostic devices
Incidence of chronic diseases such as cancer, diabetes, HIV, tuberculosis, and cardiovascular conditions is increasing, which is expected to positively impact growth of the rapid medical diagnostic devices market. For instance, according to American Diabetes Association (ADA) around 30.3 million population in U.S. was suffering from diabetes in 2015 and around 1.5 million people are diagnosed with the disease every year. Moreover, according to the World Health Organization (WHO), an estimated 36.7 million people were suffering from HIV globally, in 2016. According to the World Health Organization (WHO), in 2015, an estimated 32,000 deaths from tuberculosis and around 3, 23,000 new cases of TB cases were reported in the European region. According to Centers for Disease Control and Prevention, 2016, the number of deaths due to heart disease increased from 596,577 in 2011 to 614,348 in 2014, i.e. 3.0% between 2011 and 2014. Moreover, death due to cancer increased by 2.6% during the same time period. Early diagnosis can play a vital role in preventing or curtailing this increasing number of death due to chronic diseases such as heart disease, and cancer. As rapid diagnostic devices are primarily used for early diagnosis, the market for rapid diagnostic devices is expected to witness rapid growth rate over the forecast period.
However, factors such as reliability of the test results, less sensitivity as compared to laboratory testing, and interference in tests resulting in inaccurate final results are expected to hinder growth of the market over the forecast period.
Some major players operating in the rapid medical diagnostic devices market include Danaher Corporation, Abbott Laboratories, Acon Laboratories, Inc., Hoffman-La Roche AG, Becton, Dickinson, and Company, Johnson & Johnson, Trinity Biotech Plc, and Siemens Healthineers.
Prevalence of chronic diseases such as cancer, diabetes, cardiovascular, and infectious diseases (tuberculosis, HIV, malaria, and sexually transmitted diseases) is rising globally, and is expected to lead to high demand for rapid diagnostic techniques and devices. Diseases such as Chikungunya virus infection, neglected infectious diseases (Chagas diseases, Dengue, Leprosy, Schistosomiasis, and others) create extensive unmet needs for rapid diagnostic tests. Though rapid diagnostic tests are available for these diseases such as rapid CHIKV IgM for Chikungunya, the accuracy of these tests is not known. Severe conditions such as multidrug-resistant tuberculosis (MDR-TB) has high prevalence in emerging economies such as India, which requires rapid diagnostic devices. For instance, according to Lancet 2017, by 2040, the percentage of MDR-TB will make up of 12.4% of the TB cases in India. Leading manufacturers with established research and development capacities could aim towards development of rapid diagnostics for such diseases and gain first mover advantage in a potential market.
Demand for decentralized testing is rising, owing to factors such as less time consuming, independence from centralized laboratories as the testing can be done on the spot without the need of laboratory facilities, and cost effectiveness, which is expected to create a conducive environment for growth of rapid medical diagnostic devices market. The market is expected to exhibit significant growth, owing to further developments in point-of-care diagnostics aimed towards impacting medical outcomes, increased adoption of rapid medical diagnostic devices, and rising prevalence of chronic diseases such as HIV, infectious diseases, and diabetes. Development of innovative rapid medical diagnostic, and wide number of applications of these ranging from cancer diagnosis to metabolic diseases is expected to fuel growth of the market. Issues associated with reliability of rapid diagnostic devices results, management related issues in remote areas, and result reliability issues are expected to hinder the market growth.
Key features of the study:
“*” marked represents similar segmentation in other categories in the respective section.
Table of Contents
*Browse 41 market data tables and 27 figures on "Rapid Medical Diagnostic Devices Market - Global forecast to 2025”.
Coherent Market Insights followsa comprehensive research methodology focused on providing the most precise market analysis. The company leverages a data triangulation model which helps company to gauge the market dynamics and provide accurate estimates. Key components of the research methodologies followed for all our market reports include:
In addition to this, Coherent Market Insights has access to a wide range of the regional and global reputed paid data bases, which helps the company to figure out the regional and global market trends and dynamics. The company analyses the industry from the 360 Degree Perspective i.e. from the Supply Side and Demand Side which enables us to provide granular details of the entire ecosystem for each study. Finally, a Top-Down approach and Bottom-Up approach is followed to arrive at ultimate research findings.
Coherent Market Insights desk research is based on a principle set of research techniques:
Coherent Market Insights has a large amount of in-house repository of industry database. This is leveraged as a burner for initiating a new research study. Key secondary sources include:
Preliminary Data Mining
The raw data is obtained through the secondary findings, in house repositories, and trade surveys. It is then filtered to ensure that the relevant information including industry dynamics, trends, and outlook is retained for further research process.
Holistic approach is used to ensure that the granular and uncommon parameters are taken into consideration to ensure accurate results. The information from the paid databases are further combined to the raw data in order to standardize it.
Coherent Statistical model
We arrive at our final research findings through simulation models. Coherent Data Analytics Model is a statistical tool that helps company to forecast market estimates. Few of the parameters considered as a part of the statistical model include:
Once the findings are derived from the statistical model, large volume of data is process to confirm accurate research results. Data analytics and processing tools are adopted to process large chunk of collected informative data. In case, a client customizes the study during the process, the research finding till then are benchmarked, and the process for new research requirement is initiated again.
This is the most crucial stage of the research process. Primary Interviews are conducted to validate the data and analysis. This helps in achieving the following purposes:
The primary research is conducted with the ecosystem players including, but not limited to:
Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.
Talk to our research consultant to design an exclusive report as per your research needs.
We aim to fulfil client's research demands with tailored research solutions.
We aim to provide research studies in quickest turnaround time and in a much cost effective manner.
We cover each industry from supply and demand side with an aim to provide a most holistic research study.
We strive to provide most accurate and reliable research findings in our research reports.